Skip to content

Dr. Sara David Kinderarts

Active Private limited companyfounded 2020active for 6 yearsKerkstraat 20, 9111 Sint-NiklaasKBO/BCE: BE 0757.596.526

Lifetime

5 annual accounts with figures on one time axis
peak of €147,011 in 2023
€146,104▲ 90.4%
peak of €112,596 in 2025
€112,596▲ 115%
peak of €309,076 in 2024
€228,076▼ 26.2%
€114,721▲ 19×
Board1 name since 2020
1 director
Documentsfilings and deeds
01-07-202630 days before the deadline
2025micro format
Gross margin from €76,745 to €146,104Result from €52,459 to €112,596Dividend €193,596Equity from €309,076 to €228,076Debts from €6,175 to €114,721Cash from €107,959 to €67,588

Key points

from the 2025 annual accounts

Equity

€228,076 ▼ 26.2%
309,0762024+112,596Profit-193,596Dividend228,0762025

Dr. Sara David Kinderarts paid out €193,596 in dividends. That is 172% of the 2025 profit.

Result

€112,596 ▲ 115%
€52,5002024€113,0002025

The result rose in 2025 from €52,459 to €112,596.

Turnover

≈ €270,000 estimated

The micro format states no turnover.

Liquidity

2.99 was 52.14 in 2024

Short-term debts rose from €5,960 to €114,594.

Filings

5 annual accounts since 2021
AprilJune31 JulyOctober20222024

The last five annual accounts were filed 16 to 31 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,977 companies had the same profile as Dr. Sara David Kinderarts has now. Each dot stands for 68 companies, two years later.

94.9%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,977 companies, not a prediction for Dr. Sara David Kinderarts. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 03-11-2020
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0757596526
Registered office moved from Sint-Niklaas to Belsele The registered office moved from Ankerstraat 138 bus 1 te 9100 Sint-Niklaas to Kerkstraat 20 te 9111 Belsele · General meeting of 27-07-2022 · Gazette deed
Incorporation Founding capital of €5,000, 100 shares · Founded by · appointed as director · published on 03-11-2020 · Gazette deed
First establishment At the time the registered office was still in Sint-Niklaas, Ankerstraat 138 bus 1.
All 15 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Sara David Kinderarts Sint-Niklaas €342,797 €146,104 66.5% -
Dr. Bart Vergauwe, Gynaecologie Ghent €340,001 €160,327 64.0% -
DR. ANNELIES VAN ERCK, Fysische Geneeskunde en Revalidatie Ghent €332,435 €139,115 23.4% -
AMBAX Merelbeke-Melle €365,244 €148,826 63.7% -
Dr. Sarah Van den Berghe gynaecoloog Deinze €310,712 €157,954 79.4% -
Dr. Anaïs Depicker - Reumatologie Merelbeke-Melle €378,791 €159,411 5.2% -
Dr. Isabelle Rooms, Dermatoloog Aalter €362,506 €166,345 33.2% -

These companies have the same main activity as Dr. Sara David Kinderarts: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €311,000 and €379,000, founded between 2020 and 2021.

Official details

Source: KBO
Status
Active since 29-10-2020Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.309.209.7149111 Sint-Niklaas, registered on 29-10-2020
Financial year end
31 December
Peppol
Reachable since 04-01-2025
Company details

Annual accounts 2025

€342,797▲ 8.7%
Filing
Filed on 01-07-2026, 30 days before the end of the filing period
Financials

Insights on Dr. Sara David Kinderarts

Dr. Sara David Kinderarts files the micro format. That format states no turnover. The gross margin fell from €146,939 in 2021 to €146,104 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Sara David Kinderarts

What is the company number of Dr. Sara David Kinderarts?
The company number of Dr. Sara David Kinderarts is 0757.596.526. The VAT number is the same number with BE in front: BE 0757.596.526.
Where is Dr. Sara David Kinderarts based?
The registered office is at Kerkstraat 20, 9111 Sint-Niklaas.Company details
What does Dr. Sara David Kinderarts do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Sara David Kinderarts?
Dr. Sara David Kinderarts is a private limited company (BV).
When was Dr. Sara David Kinderarts founded?
Dr. Sara David Kinderarts was founded on 29-10-2020.
Is Dr. Sara David Kinderarts still active?
Yes, Dr. Sara David Kinderarts is an active enterprise in the KBO register.
What is the turnover of Dr. Sara David Kinderarts?
The turnover in financial year 2025 is about €270,000. This figure is estimated from the gross margin of €146,104 and 40 comparable companies (NACE 86220). It probably lies between €230,000 and €360,000.Financials
Is Dr. Sara David Kinderarts profitable?
In financial year 2025, Dr. Sara David Kinderarts made a profit of €112,596.
Where can I find the annual accounts of Dr. Sara David Kinderarts?
Dr. Sara David Kinderarts filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Sara David Kinderarts due?
Dr. Sara David Kinderarts must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.